Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
Sponsor: Menarini Silicon Biosystems, INC
Summary
The purpose of this research is to learn if the CellSearch Circulating Tumor Cells (CTC) test can help doctors in making decisions about treatment and monitoring of breast cancer. The test consists of diagnostic CTC counts (enumeration) and expression of biomarkers Human Epidermal growth factor Receptor 2 (HER2), Estrogen Receptor (ER), and programmed death-ligand 1 (PD-L1) and cell free DNA/RNA (cfDNA/RNA) analysis.
Official title: CTC-EXPRESS: A Prospective Observational Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
187
Start Date
2026-03-13
Completion Date
2028-10
Last Updated
2026-03-18
Healthy Volunteers
No
Conditions
Locations (1)
UPMC Magee Womens Hospital
Pittsburgh, Pennsylvania, United States